Smith, Moore & Co’s iShares Global Healthcare ETF IXJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,205
Closed -$201K 523
2025
Q1
$201K Buy
+2,205
New +$200K 0.02% 467
2024
Q4
Sell
-2,203
Closed -$216K 491
2024
Q3
$216K Hold
2,203
0.02% 431
2024
Q2
$205K Buy
2,203
+1
+0% +$91 0.02% 425
2024
Q1
$205K Buy
+2,202
New +$199K 0.02% 411

Other funds holding IXJ

Smith, Moore & Co's IXJ Position: Q2 2025 in Review

Smith, Moore & Co sold out of iShares Global Healthcare ETF (IXJ) in Q2 2025, closing a stake of 2,205 shares — an estimated $201K sold.

Smith, Moore & Co first reported a position in IXJ in Q1 2024 and held it in 4 quarters. The position peaked at $216K in Q3 2024. 268 funds tracked by Wall St. Rank hold IXJ as of Q2 2025.

  • Smith, Moore & Co reported no remaining iShares Global Healthcare ETF position as of Q2 2025 after selling out during the quarter.
  • Smith, Moore & Co sold 2,205 iShares Global Healthcare ETF shares in Q2 2025, an estimated $201K.
  • Smith, Moore & Co first reported a position in iShares Global Healthcare ETF in Q1 2024 and held it in 4 quarters.
  • Smith, Moore & Co's iShares Global Healthcare ETF position peaked at $216K in Q3 2024.
  • 268 funds tracked by Wall St. Rank held iShares Global Healthcare ETF as of Q2 2025.

Based on Smith, Moore & Co's 13F filing for Q2 2025, filed 13 Aug 2025.